# Interactions between Streptococcus agalactiae and Candida albicans affect persistence and virulence

**Authors:** Kathryn Patenaude, Chloe N. Bossow, Anna Lane, Marc St-Pierre, Robert T. Wheeler, Melody N. Neely

PMC · DOI: 10.1128/iai.00528-25 · Infection and Immunity · 2026-01-07

## TL;DR

This study explores how interactions between two microbes, Streptococcus agalactiae and Candida albicans, affect infection severity and treatment outcomes.

## Contribution

The study reveals that co-infections of GBS and C. albicans increase virulence and reduce antibiotic effectiveness in certain infection models.

## Key findings

- Co-infections of GBS and C. albicans in the otic vesicle of zebrafish showed increased virulence compared to solo infections.
- The presence of C. albicans reduced the effectiveness of certain antibiotics against GBS in vitro.
- Clindamycin was less effective in preventing mortality during co-infections compared to solo GBS infections.

## Abstract

Streptococcus agalactiae (Group B Streptococcus or GBS), a Gram-positive bacterium, and Candida albicans, a polymorphic fungus, are commensal microbes in most of the population they colonize. However, for certain patients, they can cause severe and sometimes fatal infections. Previous research has indicated that GBS and C. albicans can synergize to enhance the colonization of GBS in the bladders of mice, but not much was known prior to this study about how interactions between GBS and C. albicans alter treatment effectiveness and infection outcome in vivo. Results showed that interactions between the two opportunistic pathogens were influenced by media nutrient availability and that the presence of C. albicans in a culture reduces the effectiveness of certain antibiotics against GBS in vitro. This study also utilized a larval zebrafish model to investigate differences in virulence in solo infections vs co-infections with both pathogens in vivo. Co-infections of GBS and C. albicans into the otic vesicle were found to have increased virulence compared to solo infections of either pathogen. Co-infection also led to an increased GBS burden compared to solo GBS infections. Co-infections of GBS and C. albicans by yolk sac injection were not more virulent than solo infections with either pathogen. However, the antibiotic clindamycin was less effective in preventing mortality in co-infections compared to solo GBS infections. Overall, these findings highlight how interactions between GBS and C. albicans can influence treatment effectiveness and virulence during infection.

## Linked entities

- **Chemicals:** clindamycin (PubChem CID 446598)
- **Species:** Streptococcus agalactiae (taxon 1311), Candida albicans (taxon 5476), Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** Co-infection (MESH:D060085), GBS (MESH:D020275), infection (MESH:D007239)
- **Chemicals:** clindamycin (MESH:D002981)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Streptococcus agalactiae (species) [taxon 1311], Candida albicans (species) [taxon 5476], Homo sapiens (human, species) [taxon 9606], Streptococcus sp. 'group B' (species) [taxon 1319], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12890033/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12890033/full.md

## References

97 references — full list in the complete paper: https://tomesphere.com/paper/PMC12890033/full.md

---
Source: https://tomesphere.com/paper/PMC12890033